What's Inside:

New Mexico has officially joined Oregon and Colorado in legalizing psilocybin therapy, with a distinct, medically integrated model now underway. Healing Advocacy Fund’s newest team member, Denali Wilson, will lead strategic support in New Mexico as the state shapes its program through upcoming rulemaking.
In Colorado, the Natural Medicine Advisory Board is considering adding ibogaine to the regulated psychedelic framework, weighing safety, cultural, and ethical sourcing issues.
Oregon’s Psilocybin Services Data Dashboard is now live, offering detailed insights into client demographics, safety, and service center activity.
HAF is compiling a list of psilocybin-related Continuing Education and Continuing Medical Education courses—submit yours today.
Community Spotlight: Go Within Collective opens in Colorado with a focus on chronic pain and heart-centered care.
Also in this issue: Colorado webinar replay, national media highlights, and the launch of Althea’s Psilocybin Outcomes Awards recognizing care excellence in Oregon.

Dear Friend,

Today I’m happy to turn our opening letter over to Denali Wilson, Healing Advocacy Fund’s Director of Strategic Support in New Mexico and our newest staff member. We first met Denali through her work as an ally to the community advocating to pass a psilocybin therapy bill through the New Mexico legislature. After that community effort was successful, Healing Advocacy Fund asked Denali to bring her years of expertise working in New Mexico to support building a program around client safety and greater access for those in need of healing. We’re thrilled that Denali has joined our team. I’ll let her take it from here.

- Taylor

On June 20, the Medical Psilocybin Act became law in New Mexico, inviting us to join Oregon and Colorado in exploring new frontiers of healing. This victory was made possible by years of work from advocates, lawmakers, healthcare providers, and community leaders. It is also just the beginning.

New Mexico’s approach to regulated psilocybin access is distinct. Our program is built as a medically integrated model, designed to support eventual insurance coverage for psychedelic therapy. Much more than in Oregon or Colorado, many critical program details are yet to be determined. These decisions will be shaped through an intensive rulemaking process over the next two years, and how we make those choices will define the kind of care system we build.

The law is different, and so is New Mexico.

We are a state shaped by deep cultural resilience and by the ongoing legacies of colonization. We have some of the highest rates of child poverty, police violence, substance use disorder, drug overdose deaths, and suicide in the country—and we also have some of the richest traditions of care, connection, and healing practices. These truths live side by side.

With the new law comes an opportunity to imagine a different kind of system, one that doesn’t replicate the harms of the past, but creates real space for healing. It’s an opportunity, and also a responsibility.

How we implement this program will matter. It will matter for those seeking safe, affordable access to care. It will matter for traditional practitioners and communities with long-standing relationships to plant medicines. It will matter for Indigenous people whose knowledge must be respected—not extracted. It will matter for people navigating trauma, addiction, and grief in a system that has not always made room for them.

The months ahead will lay the foundation for the system we build. Right now, the Department of Health is reviewing applicants for an advisory board, which will work closely with the agency to guide the rulemaking process and, ultimately, shape the statewide program. With this first step, the real work begins.

Each additional step along the way will present choices that define what this program becomes. As the new Healing Advocacy Fund Director of Strategic Support in New Mexico, I am here to help steward this process with humility, curiosity, and care. With the benefit of Healing Advocacy Fund's experience in Oregon and Colorado, I’m looking forward to bringing the lessons learned from other state-regulated psychedelic programs to help inform a model that meets New Mexico’s unique needs and values. As a lifelong resident of New Mexico, I’m here to listen, to learn, and to help build something rooted in our shared commitments to safety, equity, and accessibility.

Those values won’t always be in perfect alignment. There will be tensions and tradeoffs. But New Mexico is the kind of place where we can hold those complexities and make something meaningful. I’m hopeful for what’s ahead, and grateful to be in this work with you.

-Denali

Denali Wilson is the New Mexico Director of Strategic Support for Healing Advocacy Fund, and the newest member of our staff. A lifelong resident of New Mexico, she is a lawyer and policy advocate based in her hometown of Las Cruces.

UPDATES

Colorado: Up to Date Numbers on Natural Medicine Program Licensing

View DOR's list of licensed healing centers in Colorado. You can also search for DORA-licensed facilitators online by selecting "Natural Medicine" from the dropdown menu.

Oregon: Up to Date Numbers on Psilocybin Services Program Licensing

View the Oregon Psilocybin Services Data Dashboard to see the most up-to-date numbers.

Colorado’s Natural Medicine Advisory Board Dives into Ibogaine

When Colorado voters directed the state to create a legal psilocybin therapy framework in 2022, they also gave Colorado state agencies the option—but not the requirement—to create a regulated therapeutic access model for other natural psychedelic medicines, including DMT, mescaline, and ibogaine.

Now that Colorado’s psilocybin therapy program is up and running, the Governor-appointed Natural Medicine Advisory Board (NMAB) has turned its attention to discussions around ibogaine, a powerful psychedelic found in the root bark of iboga, a plant that grows in Central Africa. Iboga is integral to Bwiti spiritual practices in Gabon and neighboring countries. Discussions around possibly adding ibogaine to Colorado’s regulatory framework require great care, due to its cultural significance, concerns around ethical sourcing, and cardiac risks when administered without appropriate screening and medical oversight.

Presentations to the NMAB this past month have delved into these considerations in great detail, while also exploring the possibility that ibogaine may have unique potential to support recovery and healing from a range of conditions, including traumatic brain injury (TBI), neurodegenerative conditions, substance use and opioid addiction, and PTSD. Its known cardiac risks combined with its federal Schedule I status have made ibogaine research difficult, which means much of the existing knowledge is informed by traditional practice, observational research, and lived experience among patients who have traveled to countries like Mexico (where ibogaine treatment is legal but not regulated).

The board has heard presentations from the conservation non-profit Blessings of the Forest, as well as ibogaine treatment providers, researchers and initiates of Bwiti. They are actively seeking additional expertise to inform their decisions, including input from representatives from Gabon and a clearer understanding of how Colorado can align with the Nagoya Protocol, an international agreement that aims to ensure communities, especially Indigenous groups, share in the benefits when others profit from the use of their traditional knowledge and genetic resources.

Oregon Psilocybin Services Data Dashboard Goes Live

Oregon’s Health Authority has launched an interactive Psilocybin Services Data Dashboard, offering publicly accessible quarterly updates on the state’s regulated psilocybin therapy program under ORS475A and SB 303. Launched in early-2025, the dashboard offers data on licensing, compliance, product sales, safety, and client and licensee demographics—all collected from service centers statewide.

Figures from 2025 show that 1,509 clients received psilocybin services from January through April 2025 (this does not include any estimated client numbers from May 2023-December 2024), with a small number of reported adverse behavioral or medical reactions. As mandated, it also includes REALD and SOGI demographic data, client age, income, county of residence, and reasons for seeking services, with client privacy protected through opt-out options and de-identification protocols in place.

Users can explore interactive pages which detail safety incidents, product sales, licensing activity, and demographic trends. The Data Dashboard is a key transparency tool for understanding the evolving landscape of Oregon’s regulated psilocybin therapy program.

For an interesting illustrative view of the data reported so far, take a look at Psychedelic Alpha’s Oregon Psilocybin Services Tracker.

Do You Offer Continuing Education Courses Related to Psilocybin Therapy? Let Us Know!

Healing Advocacy Fund is building a resource list of psilocybin-related continuing education (CE) and continuing medical education (CME) opportunities. If you or your organization is hosting a relevant course, workshop, or training, please take a moment to submit it using this short form: Submit a Course. This will help keep our community informed about the continuing education opportunities available for professionals in the field.

COMMUNITY SPOTLIGHT

Lakewood Healing Center Opens with Special Focus on Chronic Pain

Go Within Collective, founded by Jillian Gordon NBC-HWC, CPC, RDH, RYT, received their healing center license this month, the fourteenth center to be approved in Colorado:

“Go Within Collective is a licensed healing center in Lakewood, CO committed to heart-centered care with an integrative lens. In addition to providing a safe, inclusive space for mental health support, we offer a unique emphasis on chronic pain conditions that often go underserved. Combining evidence-based practices with spiritual depth, we aim to support each client's full-body transformation—physically, emotionally, and spiritually. We are passionate about educating mental health and healthcare professionals about harm reduction principles to promote safety and strengthen our community. Our work is rooted in compassion, education, and accessibility, ensuring that this powerful medicine is available to those who need it most.”

A note from the founder:
“As the co-founder and CEO of Go Within Collective, my dedication to this work is shaped by my own healing journey as a survivor of complex and relational trauma, which informs my belief in the transformative power of integrative, heart-centered care. My background includes years of practice with mentorship alongside extensive training in trauma-informed care, pain neuroscience, nervous system regulation, somatic awareness, and movement-based modalities. I’m proud to be leading one of Colorado’s first licensed centers, with a mission to expand access to psychedelic healing through community access, education, and body-based practices that support long-term nervous system resilience.”

> Learn more about Go Within Collective

RESOURCES

Webinar Recording: Colorado Psilocybin Therapy Program Launch

On July 10, HAF teamed up with Mental Health Colorado to host a Colorado Psilocybin Therapy Program Launch webinar, which provides an overview of how clients can access psilocybin therapy in Colorado's regulated program.

The session includes Q&A with Dr. Scott Shannon, a psychiatrist, psychedelic researcher and co-founder of the Wholeness Center, an integrative mental health clinic and licensed psilocybin healing center in Fort Collins. Dr. Shannon provides helpful information about who may be a right fit for psilocybin therapy and how the regulated program is designed to support individualized care plans responsive to client needs.

The session highlights real-world research taking place in Oregon's state-regulated psilocybin therapy program and how the research can support efforts to expand affordable access.

> Watch the recording

Althea Announces “Psilocybin Outcomes Awardees,” Recognizing Leaders Demonstrating ‘Exceptional Care and Results’ in Oregon’s Psilocybin Community

A note from Althea about their first-ever Psilocybin Outcomes Awards:

“At Althea, we believe healing should be intentional, trusted, and measurable. As access to psilocybin therapy expands, so does the need for clarity about what truly works for participants, for practitioners, and for the future of the field.

“That’s why we’re proud to launch the inaugural Psilocybin Outcomes Awards. It is a new program recognizing facilitators and centers who are delivering exceptional outcomes in legal psilocybin care. 2025 Awardees are limited to Oregon. (But we’re looking forward to expanding the pool in 2026 to Colorado as that program starts measuring outcomes!)

These awards are grounded not in opinion or hype, but in real participant-reported data: improvements in mental health, experiences of mystical insight, feelings of safety, and trust in the people guiding the journey.”

> Learn more about the Awardees

EVENTS

State Psilocybin Programs: Therapy and Legislation in the Southwest

Join in for a Virtual Community Forum from Chacruna on State Psilocybin Programs, covering Colorado and New Mexico with experts including Joaquin Orozco, Amy Wong Hope, MSW, LCSW, Josh Kappel, Jessica ‘Jaz’ Cadoch, and Tamar Todd, JD.

> Learn more and register

IN THE NEWS

Colorado Leaders Plan for the Next Wave of Psychedelic Movement

Denver Post

With the recent rollout of Colorado’s psilocybin therapy industry, the state has cemented its place at the forefront of the psychedelic movement. And if all goes well, local leaders hope to create a model that not only serves as a blueprint for other states but also helps inform how psychedelic modalities can be introduced into the broader American health care system.

> Read the article

Colorado, Oregon are Leading More Than 20 Other States in Reform of Psychedelic Policy

Colorado Sun

The federal government does not appear ready to pick up the reins and guide the growing wave of psychedelic therapies evolving across the country. So that leaves the states — led by Oregon and Colorado — to forge first-ever regulations that allow people to use psychedelics such as psilocybin, ibogaine and MDMA to treat mental health and addiction issues.

> Read the article

RFK Jr Floats Greenlighting Psychedelic Therapy. What Does This Mean for Oregon's Psilocybin Industry?

KGW

After lobbying for years about the benefits of currently illegal mind-altering substances for those struggling with post-traumatic stress disorder (PTSD), depression and other chronic health conditions, the industry may be getting a break from an unexpected source.

> Read the article

Mushrooms for Moms: Colorado Researchers Find Positive Effects in Psilocybin Medication for Postpartum Depression

WRAL News

For some, the first few months of motherhood can be magical. For others, they can struggle with postpartum depression. Researchers at University of Colorado Anschutz Medical Campus are testing medication that could help using psilocybin magic mushrooms.

> Watch the video

The Work in New Mexico